Haxhiu I, Yami A, Tubi LQ, Dekha JU, Ceccato J, Danesin N, Scapinello G, Carraro M, Visentin A, Vianello F, Trentin L, Manni S, Piazza F. P080 | Targeting CK2 disrupts epigenetic plasticity and sensitizes diffuse large B-cell lymphoma cells to the EZH2 inhibitor tazemetostat: I. Haxhiu1|2, A. Yami1|2|3, L. Quotti Tubi1|2, J. Uddin Dekha1|2|3, J. Ceccato1|2, N. Danesin1, G. Scapinello1, M. Carraro1, A. Visentin1, F. Vianello1|2, L. Trentin1, S. Manni1|2, F. Piazza1|2 | 1Hematology Unit, Department of Medicine, University of Padova; 2Veneto Institute of Molecular Medicine; 3Department of Surgery, Oncology and Gastroenterology, University of Padova. Haematologica 2026; 111(s1); https://doi.org/10.3324/haematol.2026.s1.142.